Vural A - Search Results

1

Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome.

Ozata M, Oktenli C, Gulec M, Ozgurtas T, Bulucu F, Caglar K, Bingol N, Vural A, Ozdemir IC. Ozata M, et al. Among authors: vural a. J Clin Endocrinol Metab. 2002 Feb;87(2):853-8. doi: 10.1210/jcem.87.2.8243. J Clin Endocrinol Metab. 2002. PMID: 11836332

2

The relationship between adiponectin levels and degree of proteinuria in patients with nephrotic and non-nephrotic proteinuria.

Oguz Y, Yilmaz MI, Acikel C, Eyileten T, Caglar K, Oktenli C, Yenicesu M, Vural A. Oguz Y, et al. Among authors: vural a. Ren Fail. 2009;31(1):29-35. doi: 10.1080/08860220802546461. Ren Fail. 2009. PMID: 19142807 Free article.

3

Oxidative stress status in adults with nephrotic syndrome.

Bulucu F, Vural A, Aydin A, Sayal A. Bulucu F, et al. Among authors: vural a. Clin Nephrol. 2000 Mar;53(3):169-73. Clin Nephrol. 2000. PMID: 10749294

4

Blockade of the renin-angiotensin system increases plasma adiponectin levels in type-2 diabetic patients with proteinuria.

Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Acikel C, Kilic S, Bingol N, Bingol S, Vural A. Yenicesu M, et al. Among authors: vural a. Nephron Clin Pract. 2005;99(4):c115-21. doi: 10.1159/000083929. Epub 2005 Feb 10. Nephron Clin Pract. 2005. PMID: 15711099

5

Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria.

Yilmaz MI, Sonmez A, Caglar K, Gok DE, Eyileten T, Yenicesu M, Acikel C, Bingol N, Kilic S, Oguz Y, Vural A. Yilmaz MI, et al. Among authors: vural a. Endocrine. 2004 Dec;25(3):207-14. doi: 10.1385/ENDO:25:3:207. Endocrine. 2004. PMID: 15758247 Clinical Trial.

6

Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.

Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C, Oguz Y, Yavuz I, Vural A. Yilmaz MI, et al. Among authors: vural a. Nephrology (Carlton). 2007 Apr;12(2):147-53. doi: 10.1111/j.1440-1797.2007.00764.x. Nephrology (Carlton). 2007. PMID: 17371337 Clinical Trial.

7

The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease.

Oguz Y, Oktenli C, Ozata M, Ozgurtas T, Sanisoglu Y, Yenicesu M, Vural A, Bulucu F, Kocar IH. Oguz Y, et al. Among authors: vural a. J Endocrinol Invest. 2003 Jul;26(7):609-15. doi: 10.1007/BF03347016. J Endocrinol Invest. 2003. PMID: 14594109

8

Adiponectin level is reduced and inversely correlated with the degree of proteinuria in type 2 diabetic patients.

Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Kir T, Acikel C, Bingol N, Oguz Y, Ikizler TA, Vural A. Yenicesu M, et al. Among authors: vural a. Clin Nephrol. 2005 Jul;64(1):12-9. doi: 10.5414/cnp64012. Clin Nephrol. 2005. PMID: 16047640

9

Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an experimental nephrotic syndrome model.

Yilmaz MI, Korkmaz A, Kaya A, Sonmez A, Caglar K, Topal T, Eyileten T, Yenicesu M, Acikel C, Oter S, Yaman H, Aktug H, Oguz Y, Vural A, Ikizler TA. Yilmaz MI, et al. Among authors: vural a. Nephron Exp Nephrol. 2006;104(1):e15-22. doi: 10.1159/000093260. Epub 2006 May 11. Nephron Exp Nephrol. 2006. PMID: 16699289

10

Acute pyelonephritis causing acute renal allograft dysfunction.

Oguz Y, Doganci L, Bulucu F, Can C, Oktenli C, Yenicesu M, Vural A. Oguz Y, et al. Among authors: vural a. Int Urol Nephrol. 2002;34(3):299-301. doi: 10.1023/a:1024495800455. Int Urol Nephrol. 2002. PMID: 12899217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters